Second patient dies in France after receiving experimental heart


(MENAFN- Kuwait News Agency (KUNA)) A second patient who was transplanted with a ground-breaking experimental heart has died here after surviving nine months with the totally-artificial device, medical sources reported Tuesday.

The second transplant of the "Carmat" heart, named after the biomedical firm that manufactured the device, was carried out last August by medical teams in the city of Nantes, western France, but the 69-year-old patient died May 2 after circulatory problems following an emergency operation, the Carmat manufacturer said.

The company said in a statement that the patient did not survive a second-transplant to replace the original "Carmat" artificial heart.

The first transplant patient with a "Carmat" battery-powered, all-composite heart died last year 74 days after his transplant.

A third transplant was carried out in early April and it is hoped this operation will last even longer than the previous two, as experiments continue with the aim of eventually carrying out 20 transplants.

Carmat vaunts its artificial heart for allowing patients to rapidly resume an almost-normal life after the operation.


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.